Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Invested Capital (2016 - 2025)

Historic Invested Capital for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $16.3 billion.

  • Fresenius Medical Care AG's Invested Capital rose 48.31% to $16.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 billion, marking a year-over-year increase of 48.31%. This contributed to the annual value of $32.1 billion for FY2024, which is 112.98% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Invested Capital of $16.3 billion as of Q3 2025, which was up 48.31% from $16.2 billion recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year Invested Capital high stood at $32.4 billion for Q4 2023, and its period low was $15.4 billion during Q2 2021.
  • For the 5-year period, Fresenius Medical Care AG's Invested Capital averaged around $18.8 billion, with its median value being $16.4 billion (2024).
  • Per our database at Business Quant, Fresenius Medical Care AG's Invested Capital surged by 3694.85% in 2023 and then plummeted by 331.24% in 2024.
  • Over the past 5 years, Fresenius Medical Care AG's Invested Capital (Quarter) stood at $24.4 billion in 2021, then fell by 2.75% to $23.7 billion in 2022, then surged by 36.95% to $32.4 billion in 2023, then decreased by 1.13% to $32.1 billion in 2024, then tumbled by 49.2% to $16.3 billion in 2025.
  • Its Invested Capital stands at $16.3 billion for Q3 2025, versus $16.2 billion for Q2 2025 and $16.4 billion for Q1 2025.